Advancing Biomanufacturing Operations: Key Takeaways from the 20th Annual Report
/PRNewswire/ -- The "20th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production" report has been added to...
Stay updated with breaking news from Cutting Actions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The "20th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production" report has been added to...
/PRNewswire/ -- The "19th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production" report has been added to...
/PRNewswire/ -- The "18th Annual Report and Survey on Biopharmaceutical Manufacturing Capacity and Production" report has been added to...
/PRNewswire/ -- The "18th Annual Report and Survey on Biopharmaceutical Manufacturing Capacity and Production" report has been added to...
On May 13, we issued an updated research report on Franco-Nevada Corp FNV. The company is well poised for growth backed by its healthy and diversified portfolio of streaming and royalty agreements, and a debt-free balance sheet. The company continues to deliver improved margins, aided by its continued focus on cost management. However, uncertainty regarding the pandemic’s impact on the company’s mining operators and decline in gold prices remain...